Prime Medicine shrinks CRISPR ambitions and gets cash infusion from Bristol Myers Squibb
Prime Medicine, a company founded with gene editing technology from Harvard biochemist…
Medical students must be protected from sexual abuse, say campaigners
Sexual safety campaigners have written to the health secretary Wes Streeting to…
New hand-held scanner generates 3D images in seconds to facilitate early diagnosis
A new hand-held scanner developed by UCL researchers can produce detailed 3D…
Biocartis appoints renowned precision oncology expert, Dr. W. Michael Korn, as Chief Medical and Scientific Officer
Dr. W. Michael Korn has been appointed as Biocartis NV's Chief Medical…
Firearm Homicides a Major Public Health Challenge in Mexico
A study conducted by experts from various institutions in the U.S. analyzed…
Poor Sleep During Pregnancy Linked To Developmental Delays In Children: Study
Poor sleep during pregnancy, specifically sleeping less than seven hours daily, can…
The FTC Is Suing PBMs Over Insulin Prices. Will It Be Successful?
The Federal Trade Commission has sued the three largest pharmacy benefit managers…
The place of religion in medically assisted dying
The content discusses the issue of doctors contributing to end-of-life care debates…
Molecular screening helpful to differentiate uveitis, inherited retinal dystrophies
Dr. Bart Leroy discusses the overlapping features of uveitis and inherited retinal…
STAT+: Pharmalittle: We’re reading about a new schizophrenia drug, a U.N. pledge on AMR and more
The U.S. FDA approved a new medication called Cobenfy by Bristol Myers…